Institutional Net Buying Sustains KOSPI Above 2540... KOSDAQ Rises Over 1%

On the 18th, news related to Pfizer's COVID-19 vaccine was displayed on a dealer's monitor in the dealing room of Hana Bank in Euljiro, Seoul. On that day, the KOSPI index opened at 2,548.85, up 9.70 points (0.38%) from the previous trading day. Photo by Moon Honam munonam@

[Asia Economy Reporter Kum Boryeong] On the afternoon of the 18th, the KOSPI index is maintaining the 2540 level due to net buying by institutional investors.

As of 1:44 PM on the day, the KOSPI index rose 0.26% (6.49 points) from the previous day to 2545.64.

The KOSPI opened at 2548.85, up 0.38% (9.70 points) compared to the previous trading day, but experienced fluctuations and briefly reversed to a decline.

In the KOSPI market, institutions net bought 117.8 billion KRW. In contrast, individuals and foreigners net sold 41.5 billion KRW and 61.5 billion KRW, respectively.

By sector, chemicals (1.29%) and pharmaceuticals (2.69%) rose, while medical precision instruments (1.16%) and transportation equipment (1%) declined.

Among the top market capitalization companies, Samsung Electronics (1.22%) and Hyundai Motor (1.64%) were on a downward trend. SK Hynix (0.1%), Samsung Biologics (4.91%), LG Chem (2.48%), NAVER (2.55%), and Celltrion (1.4%) showed upward trends.

At the same time, the KOSDAQ index recorded 850.43, up 1.31% (10.96 points) from the previous trading day, maintaining a strong performance.

The KOSDAQ opened at 842.55, up 0.37% (3.08 points) from the previous session, and extended its gains.

In the KOSDAQ market, foreigners and institutions net bought 167.2 billion KRW and 7.9 billion KRW, respectively, while individuals net sold 128.8 billion KRW.

By sector, telecommunications equipment (1.83%), pharmaceuticals (2.49%), non-metallic minerals (2.33%), and textiles & apparel (1.58%) rose.

Among the top 10 companies by market capitalization, Seegene (0.14%) was the only one to decline. Celltrion Healthcare (2.01%), HL Biopharma (0.54%), Alteogen (0.61%), and Celltrion Pharm (0.96%) rose.

This content was produced with the assistance of AI translation services.